BioStar Capital, a value-add investment firm focused on transitional medical technologies, announced that Jeffrey Yau, VP of Data Science, Data Engineering, and Platform Engineering at Walmart Global Technology has joined the firm as an entrepreneur in residence (EIR).
As an EIR, Dr. Yau will expand BioStar’s expertise within the emerging field of data science and artificial intelligence (AI) in healthcare, as well as identify and evaluate startups with high-growth potential
Dr. Yau joins a unique team combining the business acumen of seasoned investment professionals, and the clinical expertise of world-renowned physicians. The BioStar team has invested in over 30 medical device startups, with nearly half acquired by major medical device manufacturers, including Boston Scientific, Medtronic, and Covidien.
“The healthcare industry has only scratched the surface of what’s possible with data-driven and AI-enabled technologies,” said Dr. Yau. “The BioStar team is well-positioned to get in on the ground floor of this trend, and I’m looking forward to identifying and nurturing startups who are shaping healthcare’s future and, just as importantly, making a meaningful impact on society as a whole.”